| scholarly article | Q13442814 |
| P50 | author | Maria Cristina Da Mosto | Q57612699 |
| P2093 | author name string | Vanna Chiarion Sileni | |
| Adriano Paccagnella | |||
| Antonio Orlando | |||
| Carlo Marchiori | |||
| Antonio Jirillo | |||
| Giovanni Luigi Pappagallo | |||
| Alessandro Gava | |||
| Lucio Loreggian | |||
| Luigi Tomio | |||
| Maria Grazia Ghi | |||
| Carlo Alberto Mione | |||
| Alessandro Bordin | |||
| Antonella Fede | |||
| Fanny Boldrin | |||
| Francesco Lunghi | |||
| Giancarlo Cavaniglia | |||
| Pier Luigi Zorat | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phase III clinical trial | Q42824827 |
| head and neck carcinoma | Q18554836 | ||
| neck cancer | Q18966654 | ||
| chemotherapy | Q974135 | ||
| head and neck cancer | Q1783924 | ||
| P304 | page(s) | 1714-1717 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up | |
| P478 | volume | 96 |
| Q51740619 | A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. |
| Q36022400 | A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas. |
| Q33491298 | A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck |
| Q88983830 | A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx |
| Q34498577 | A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer |
| Q42863527 | Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer |
| Q36462747 | Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region |
| Q43148494 | Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue |
| Q37930854 | Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma: an evidence-based meta-analysis |
| Q40060938 | Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone |
| Q43209150 | Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. |
| Q37469917 | Diffusion-weighted imaging in head and neck cancers |
| Q37170947 | Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. |
| Q47926809 | Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study |
| Q40310924 | Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer |
| Q39193669 | Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study |
| Q37126351 | Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer |
| Q37791776 | Empowering induction therapy for locally advanced head and neck cancer |
| Q44792291 | Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma |
| Q44808667 | Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer |
| Q54152939 | Head and neck cancer |
| Q61814264 | Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief |
| Q36697794 | Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis |
| Q36613979 | Induction chemotherapy in the management of squamous cell carcinoma of the head and neck |
| Q52884293 | Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma. |
| Q37799933 | Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer |
| Q24242951 | Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment |
| Q24235229 | Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy |
| Q24235245 | Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy |
| Q40158675 | Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer |
| Q40421238 | Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomas |
| Q54729777 | MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. |
| Q99552003 | MMP2 as an independent prognostic stratifier in oral cavity cancers |
| Q39370399 | National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma |
| Q46318004 | Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma |
| Q90650174 | Neoadjuvant chemotherapy followed by surgery for HPV-associated locoregionally advanced oropharynx cancer |
| Q46087306 | Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck |
| Q96133061 | Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China |
| Q37206229 | Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan |
| Q38619293 | Pharmacotherapy of head and neck cancer |
| Q45221883 | Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer |
| Q34369298 | Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio |
| Q83864103 | Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study) |
| Q38830809 | Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer |
| Q44783059 | Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging |
| Q33483238 | Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck |
| Q37093034 | Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck |
| Q36524702 | Reassessment of the role of induction chemotherapy for head and neck cancer |
| Q39658589 | Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer |
| Q33380006 | Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer |
| Q44536370 | Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation |
| Q43978706 | Strategies for non-resectable head and neck cancer |
| Q36529843 | Systemic therapy strategies for head-neck carcinomas: Current status |
| Q37149342 | Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications |
| Q50088438 | The Italian Collaborative Group sets a standard for the treatment of locally advanced head and neck cancer |
| Q89622380 | The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality |
| Q57458511 | The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series |
| Q26859285 | The role of systemic treatment before, during, and after definitive treatment |
| Q38038836 | Update on role of chemotherapy in head and neck squamous cell cancer |
| Q83706852 | [Radiotherapy, chemotherapy and target therapy for treatment of head and neck cancer : new developments] |
| Q41382440 | p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer |
Search more.